ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 265

Disparities in Utilization and Direct Costs of Hospitalizations and Emergency Room Visits in SLE: The Georgia Lupus Registry

S. Sam Lim1, Cristina Drenkard1, Gaobin Bao1, Jayanti Mukherjee2, Sean E. Connolly2, Andrew Napoli2, Damemarie Paul2 and Evo Alemao2, 1Emory University, Atlanta, GA, 2Bristol-Myers Squibb, Princeton, NJ

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Lupus and economics

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Healthcare Disparities in Rheumatology Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: There is a lack of population-based statistics on utilization and costs of direct healthcare of systemic lupus erythematosus (SLE) in the US, which disproportionately impacts blacks. Data are limited to those from databases, such as Medicaid and commercial claims, which cannot validate SLE diagnoses on a larger scale. To overcome these limitations, we utilized a population-based registry to evaluate healthcare utilization and direct costs in SLE. Methods: The Georgia Lupus Registry is a Centers for Disease Control and Prevention-funded population-based registry of validated SLE patients in Atlanta, GA, from 2002–04. The state privacy exemption for public health surveillance allowed diagnoses to be validated without consent on a population level, using ≥4 ACR criteria or 3 ACR criteria with a final diagnosis of SLE by a board-certified rheumatologist. Validated incident patients were matched with the state Hospital Discharge Database from 2000–13, which captured all hospital and emergency room (ER) admissions. Direct costs were reported according to the latest Medicare reimbursement rates, regardless of insurance or lack thereof. Patients were censored at death. Results: Of 336 incident patients, 86.9% were female, 73.8% black, 22.9% white and 58.9% unmarried; 246 (73.2%) were admitted to hospital and 257 (76.5%) to the ER (Table 1). Patients admitted to the ER and hospital were significantly more likely to be black and have serositis. Hospitalized patients were also more likely to have a renal disorder and meet a greater number of ACR criteria (Table 1). Overall, 1255 hospitalizations had a total cost of $56,365,119 (Table 2). The hospitalization rate was higher in blacks and those with renal disorders. Charges per hospitalization were higher in whites compared with blacks and in those with renal involvement. Length of stay per admission was similar across all groups (6–8 days) (Table 2). There were 2004 ER admissions with a total cost of $4,818,097. The ER admission rate was highest in the blacks and those with renal involvement. Charges per ER admission were similar by sex and in those with renal involvement, but were higher in whites compared with blacks (Table 2).

Conclusion: SLE has significant healthcare utilization and cost burden. A large proportion of patients are admitted to the ER or hospital. Blacks and those with early renal involvement have a higher rate of hospital and ER admissions. Despite having fewer hospital and ER admissions, whites incurred higher charges per admission than blacks. Further study of factors that drive healthcare utilization and cost is needed.


 

Disclosure: S. S. Lim, None; C. Drenkard, Centers for Disease Control and Prevention (CDC) grant U01DP005119; NIH (R01AR065493-01; R01MD010455-01; R01AR070898-01), 2,Emory University, 3; G. Bao, None; J. Mukherjee, Bristol-Myers Squibb, 1, 3; S. E. Connolly, Bristol-Myers Squibb, 1, 3; A. Napoli, Bristol-Myers Squibb, 1, 3; D. Paul, Bristol-Myers Squibb, 3; E. Alemao, Bristol-Myers Squibb, 1, 3.

To cite this abstract in AMA style:

Lim SS, Drenkard C, Bao G, Mukherjee J, Connolly SE, Napoli A, Paul D, Alemao E. Disparities in Utilization and Direct Costs of Hospitalizations and Emergency Room Visits in SLE: The Georgia Lupus Registry [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/disparities-in-utilization-and-direct-costs-of-hospitalizations-and-emergency-room-visits-in-sle-the-georgia-lupus-registry/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disparities-in-utilization-and-direct-costs-of-hospitalizations-and-emergency-room-visits-in-sle-the-georgia-lupus-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology